ETF

iShares Nasdaq US Biotech ETF USD Acc

ISIN
IE00BYXG2H39

How good is this fund, really?

See the rating in the app

About iShares Nasdaq US Biotech ETF USD Acc

NASDAQ-listed biotechnology and pharmaceutical companies, classified under the Industry Classification Benchmark, make up the NASDAQ Biotechnology Index that iShares Nasdaq US Biotech ETF USD Acc tracks. Constituents must meet the index provider's minimum market capitalisation and liquidity rules, and a modified market-cap weighting limits any single company to 8%, with no more than five at that cap; excess weight is spread across the rest. BlackRock intends to replicate the index by holding its shares. Income is reinvested in this US dollar class. It belongs to iShares IV plc and was launched in 2017. With a risk rating of 6 out of 7, it has ongoing charges of 0.35%.

Watch this fund for free Add iShares Nasdaq US Biotech ETF USD Acc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy iShares Nasdaq US Biotech ETF USD Acc — platforms and fees

Sold on 4 platforms we follow.

iShares Nasdaq US Biotech ETF USD Acc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds